tiprankstipranks
Wakamoto Pharmaceutical Co., Ltd. (JP:4512)
:4512
Japanese Market
4512
Wakamoto Pharmaceutical Co., Ltd.
RESEARCH TOOLSreports
Want to see JP:4512 full AI Analyst Report?

Wakamoto Pharmaceutical Co., Ltd. (4512) Income Statement

0 Followers

Wakamoto Pharmaceutical Co., Ltd. Income Statement

Last quarter (Q3 2023), Wakamoto Pharmaceutical Co., Ltd.'s total revenue was ¥1.97B, a decrease of -12.47% from the same quarter last year. In Q3, Wakamoto Pharmaceutical Co., Ltd.'s net income was ¥17.26M. See Wakamoto Pharmaceutical Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Revenue
¥ 9.91B¥ 7.79B¥ 7.74B¥ 8.66B¥ 8.38B
Gross Profit
¥ 4.73B¥ 3.62B¥ 3.54B¥ 4.11B¥ 4.36B
Operating Expenses
¥ 4.47B¥ 4.08B¥ 3.74B¥ 3.97B¥ 4.37B
Depreciation and Amortization
¥ 442.93M¥ 430.34M¥ 345.45M¥ 363.65M¥ 470.08M
EBITDA
¥ 698.48M¥ 438.68M¥ 504.84M¥ 575.81M¥ 755.52M
Operating Income
¥ 255.54M¥ -457.80M¥ -195.51M¥ 141.47M¥ -13.39M
Other Income/Expenses
¥ 852.00K¥ 465.25M¥ 354.37M¥ 70.11M¥ 298.24M
Pretax Income
¥ 256.40M¥ 7.46M¥ 158.85M¥ 211.57M¥ 284.86M
Net Income
¥ 227.22M¥ 64.44M¥ 108.96M¥ 138.26M¥ 238.54M
Per Share Metrics
Basic EPS
¥ 6.55¥ 1.86¥ 3.14¥ 3.98¥ 6.87
Diluted EPS
¥ 6.55¥ 1.86¥ 3.14¥ 3.98¥ 6.87
Weighted Average Shares Outstanding
 34.71M 34.71M 34.71M 34.71M 34.71M
Weighted Average Shares Outstanding (Diluted)
 34.71M 34.71M 34.71M 34.71M 34.71M
Currency in JPY

Wakamoto Pharmaceutical Co., Ltd. Earnings and Revenue History